JP7060878B2 - メトトレキサート含有フィルムコーティング錠 - Google Patents

メトトレキサート含有フィルムコーティング錠 Download PDF

Info

Publication number
JP7060878B2
JP7060878B2 JP2018530358A JP2018530358A JP7060878B2 JP 7060878 B2 JP7060878 B2 JP 7060878B2 JP 2018530358 A JP2018530358 A JP 2018530358A JP 2018530358 A JP2018530358 A JP 2018530358A JP 7060878 B2 JP7060878 B2 JP 7060878B2
Authority
JP
Japan
Prior art keywords
film
coating layer
film coating
coated
content
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2018530358A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2018021416A1 (ja
Inventor
憲志 片岡
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nippon Zoki Pharmaceutical Co Ltd
Original Assignee
Nippon Zoki Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Zoki Pharmaceutical Co Ltd filed Critical Nippon Zoki Pharmaceutical Co Ltd
Publication of JPWO2018021416A1 publication Critical patent/JPWO2018021416A1/ja
Application granted granted Critical
Publication of JP7060878B2 publication Critical patent/JP7060878B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
JP2018530358A 2016-07-27 2017-07-26 メトトレキサート含有フィルムコーティング錠 Active JP7060878B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2016147700 2016-07-27
JP2016147700 2016-07-27
PCT/JP2017/027066 WO2018021416A1 (ja) 2016-07-27 2017-07-26 メトトレキサート含有フィルムコーティング錠

Publications (2)

Publication Number Publication Date
JPWO2018021416A1 JPWO2018021416A1 (ja) 2019-05-23
JP7060878B2 true JP7060878B2 (ja) 2022-04-27

Family

ID=61016221

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018530358A Active JP7060878B2 (ja) 2016-07-27 2017-07-26 メトトレキサート含有フィルムコーティング錠

Country Status (4)

Country Link
JP (1) JP7060878B2 (zh)
CN (1) CN109475557B (zh)
TW (1) TWI728156B (zh)
WO (1) WO2018021416A1 (zh)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2021008444A (ja) * 2019-06-28 2021-01-28 日本ジェネリック株式会社 メトトレキサートを含むフィルムコーティング錠

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003300872A (ja) 2002-04-11 2003-10-21 Ss Pharmaceut Co Ltd 被覆固形催眠製剤
WO2013021660A1 (ja) 2011-08-08 2013-02-14 株式会社 三和化学研究所 アゾセミドを有効成分とするコーティング製剤
JP2013035797A (ja) 2011-08-10 2013-02-21 Kyowa Yakuhin Kogyo Kk ピタバスタチンを含有する錠剤
WO2013054872A1 (ja) 2011-10-14 2013-04-18 大塚製薬株式会社 ７－［４－（４－ベンゾ［ｂ］チオフェン－４－イル－ピペラジン－１－イル）ブトキシ］－１Ｈ－キノリン－２－オン又はその塩を含む錠剤
JP2015013857A (ja) 2013-06-06 2015-01-22 武田薬品工業株式会社 被覆製剤

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE241341T1 (de) * 1997-09-10 2003-06-15 Takeda Chemical Industries Ltd Stabilisierte pharmazeutische zusammensetzung
JP4730985B2 (ja) * 1997-09-10 2011-07-20 武田薬品工業株式会社 安定化された医薬製剤
CN1320887C (zh) * 2004-09-28 2007-06-13 马晶 一种甲氨蝶呤口腔崩解片及其制备方法
WO2010038771A1 (ja) * 2008-09-30 2010-04-08 中外製薬株式会社 光安定化された医薬組成物
JP2016155777A (ja) * 2015-02-25 2016-09-01 日本ジェネリック株式会社 モンテルカスト又はその塩を含む組成物

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003300872A (ja) 2002-04-11 2003-10-21 Ss Pharmaceut Co Ltd 被覆固形催眠製剤
WO2013021660A1 (ja) 2011-08-08 2013-02-14 株式会社 三和化学研究所 アゾセミドを有効成分とするコーティング製剤
JP2013035797A (ja) 2011-08-10 2013-02-21 Kyowa Yakuhin Kogyo Kk ピタバスタチンを含有する錠剤
WO2013054872A1 (ja) 2011-10-14 2013-04-18 大塚製薬株式会社 ７－［４－（４－ベンゾ［ｂ］チオフェン－４－イル－ピペラジン－１－イル）ブトキシ］－１Ｈ－キノリン－２－オン又はその塩を含む錠剤
JP2015013857A (ja) 2013-06-06 2015-01-22 武田薬品工業株式会社 被覆製剤

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
抗リウマチ剤 日本薬局方 メトトレキサートカプセル リウマトレックスカプセル2mg 添付文書，第19版，2016年02月，pp. 1-6
葉酸代謝拮抗剤 メソトレキセート錠2.5mg 添付文書，第13版，2016年02月，pp. 1-3，p.1上欄, p.3 右欄

Also Published As

Publication number Publication date
CN109475557A (zh) 2019-03-15
JPWO2018021416A1 (ja) 2019-05-23
CN109475557B (zh) 2022-01-07
WO2018021416A1 (ja) 2018-02-01
TWI728156B (zh) 2021-05-21
TW201808296A (zh) 2018-03-16

Similar Documents

Publication Publication Date Title
JP5798641B2 (ja) 経口投与用医薬組成物
WO2004054574A1 (ja) 経口固形医薬
KR20170083071A (ko) 광에 대해서 불안정한 약물을 함유하는 다층 정제
JP2024045760A (ja) 医薬組成物
JP2022088683A (ja) 医薬組成物
US20150157628A1 (en) Pharmaceutical compositions of Lurasidone and Process for preparation thereof
WO2019004448A1 (ja) 医薬組成物
JP7060878B2 (ja) メトトレキサート含有フィルムコーティング錠
JP2015054851A (ja) 被覆経口固形製剤
JP2018123097A (ja) エレトリプタン臭化水素酸塩含有口腔内崩壊錠
JP2016155777A (ja) モンテルカスト又はその塩を含む組成物
JP2020121950A (ja) 固形製剤
JP2022020459A (ja) ニロチニブ錠剤
JP5791817B2 (ja) 溶出性及び／又は吸収性が改善された経口投与用医薬組成物
JP6765473B2 (ja) オルメサルタンのプロドラッグ製剤
KR102585644B1 (ko) 1-(3-시아노-1-아이소프로필-인돌-5-일)피라졸-4-카르복실산을 포함하는 경구용 제제
JP2023051897A (ja) 溶出性に優れ、変色を防止したエルトロンボパグオラミンを含む錠剤
JP2022184792A (ja) アジルサルタンまたは薬学的に許容されるその塩を含む口腔内崩壊錠
Meenakshisunderam 2) Patent Application Publication o Pub. No.: US 2015/0157628A1
JP2011241181A (ja) クエチアピンフマル酸塩含有経口用錠剤
JP2018016609A (ja) バゼドキシフェン酢酸塩を含む固形製剤及びその製造方法
JP2012041290A (ja) ラフチジン含有固形製剤

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20200917

A917 Reason for reinstatement of right to file examination request

Free format text: JAPANESE INTERMEDIATE CODE: A917

Effective date: 20200917

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20210719

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20210909

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20211116

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20220404

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20220408

R150 Certificate of patent or registration of utility model

Ref document number: 7060878

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150